Schielen J G, Adams H P, Voskuilen M, Tesser G J, Nieuwenhuizen W
Gaubius Laboratory IVVO-TNO, Leiden, The Netherlands.
Biochem J. 1991 Jun 15;276 ( Pt 3)(Pt 3):655-9. doi: 10.1042/bj2760655.
The sequence fibrinogen-A alpha-(148-160) can mimic part of the fibrin-induced rate enhancement of the activation of plasminogen by tissue-type plasminogen activator. Previously we have reported that the lysine residue at position A alpha-157 is crucial. During our further investigations on A alpha-157 we found that lysine at position A alpha-157 may be replaced by glutamic acid. This unexpected finding prompted us to re-investigate the requirements of this position. We prepared analogues of A alpha-(148-160) in which the lysine residue at position A alpha-157 was replaced by lysine derivatives (acetyl-lysine, benzyloxycarbonyl-lysine and methanesulphonylethyloxycarbonyl-lysine), acidic residues (aspartic acid and glutamic acid), basic residues (arginine and ornithine), polar residues (glutamine and methanesulphonylethyloxycarbonylornithine), apolar residues (alanine, valine, norleucine and glutamic acid 4-nitrobenzyl ester) and glycine. These analogues were tested for their stimulatory activity. When aspartic acid, glutamic acid 4-nitrobenzyl ester or norleucine is present at position A alpha-157 in A alpha-(148-160) virtually all stimulatory capacity is lost. With valine at position A alpha-157 the stimulatory activity is marginal. None of the other replacements at position A alpha-157 caused loss of rate-enhancing properties. From these results we conclude that for the rate-enhancing effect of A alpha-(148-160) the side chain of the amino acid residue at position A alpha-157 must fulfill certain requirements: there must be one (as in alanine) or no (as in glycine) carbon atom in the side chain, or at least two carbon atoms and a polar group (charged or uncharged) to which a rather bulky group (such as the benzyloxycarbonyl group) or a polar group (such as the methanesulphonylethyloxycarbonyl group) may be attached. The highest activity [even higher than native A alpha-(148-160)] was obtained with ornithine, methanesulphonylethyloxycarbonylornithine or methanesulphonylethyloxycarbonyl-lysine at position A alpha-157.
纤维蛋白原 -Aα-(148 - 160)序列可模拟纤维蛋白诱导的组织型纤溶酶原激活剂激活纤溶酶原速率增强的部分作用。此前我们报道过,Aα-157位的赖氨酸残基至关重要。在我们对Aα-157的进一步研究中,发现Aα-157位的赖氨酸可能被谷氨酸取代。这一意外发现促使我们重新研究该位置的要求。我们制备了Aα-(148 - 160)的类似物,其中Aα-157位的赖氨酸残基被赖氨酸衍生物(乙酰赖氨酸、苄氧羰基赖氨酸和甲磺酰乙氧羰基赖氨酸)、酸性残基(天冬氨酸和谷氨酸)、碱性残基(精氨酸和鸟氨酸)、极性残基(谷氨酰胺和甲磺酰乙氧羰基鸟氨酸)、非极性残基(丙氨酸、缬氨酸、正亮氨酸和谷氨酸4 - 硝基苄酯)以及甘氨酸取代。测试了这些类似物的刺激活性。当Aα-(148 - 160)中Aα-157位存在天冬氨酸、谷氨酸4 - 硝基苄酯或正亮氨酸时,几乎所有刺激能力都丧失。Aα-157位为缬氨酸时,刺激活性微弱。Aα-157位的其他取代均未导致速率增强特性的丧失。从这些结果我们得出结论,对于Aα-(148 - 160)的速率增强作用,Aα-157位氨基酸残基的侧链必须满足一定要求:侧链中必须有一个(如丙氨酸)或没有(如甘氨酸)碳原子,或者至少有两个碳原子和一个极性基团(带电荷或不带电荷),一个相当大的基团(如苄氧羰基)或一个极性基团(如甲磺酰乙氧羰基)可以连接到该极性基团上。Aα-157位为鸟氨酸、甲磺酰乙氧羰基鸟氨酸或甲磺酰乙氧羰基赖氨酸时,获得了最高活性[甚至高于天然的Aα-(148 - 160)]。